Dru Riddle1, Mat Gregoski2, Kathy Baker3, Bonnie Dumas2, Carolyn H Jenkins2. 1. Center for Evidence Based Practice & Research: A Collaborating Center of the Joanna Briggs Institute, School of Nurse Anesthesia, Texas Christian University, TCU Box 298626, Fort Worth, TX 76129, USA. 2. College of Nursing, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, USA. 3. Division of Graduate Nursing & Scholarship, Harris College of Nursing & Health Sciences, Texas Christian University, TCU Box 298626, Fort Worth, TX 76129, USA.
Abstract
AIM: Pharmacogenomic testing is useful in helping to predict and explain patient responsiveness to medication. In clinical practice, the use of pharmacogenomic testing has been shown to help reduce adverse drugs events and increase patient satisfaction with their healthcare. Prior to a test being useful, it must have clinical utility. There is a gap in the literature about the perceived clinical utility of pharmacogenomic testing among anesthesia providers. METHODS: This qualitative-quantitative sequential mixed-method study used focused interviews to formulate probes for a quantitative survey aimed at quantifying the perceptions of anesthesia providers about pharmacogenomic testing. RESULTS: The results indicate anesthesia providers do not have enough knowledge about pharmacogenomic testing for it to be considered clinically useful in anesthesia practice. CONCLUSION: Although outcomes data indicate pharmacogenomic testing can help predict outcomes, anesthesia providers do not have enough knowledge and have concerns about the ethical implications of pharmacogenomic testing.
AIM: Pharmacogenomic testing is useful in helping to predict and explain patient responsiveness to medication. In clinical practice, the use of pharmacogenomic testing has been shown to help reduce adverse drugs events and increase patient satisfaction with their healthcare. Prior to a test being useful, it must have clinical utility. There is a gap in the literature about the perceived clinical utility of pharmacogenomic testing among anesthesia providers. METHODS: This qualitative-quantitative sequential mixed-method study used focused interviews to formulate probes for a quantitative survey aimed at quantifying the perceptions of anesthesia providers about pharmacogenomic testing. RESULTS: The results indicate anesthesia providers do not have enough knowledge about pharmacogenomic testing for it to be considered clinically useful in anesthesia practice. CONCLUSION: Although outcomes data indicate pharmacogenomic testing can help predict outcomes, anesthesia providers do not have enough knowledge and have concerns about the ethical implications of pharmacogenomic testing.
Authors: David A Fishbain; Dana Fishbain; John Lewis; R B Cutler; Brandly Cole; H L Rosomoff; R Steele Rosomoff Journal: Pain Med Date: 2004-03 Impact factor: 3.750
Authors: Jorja Collins; Brenda Bertrand; Veronica Hayes; Sherly X Li; Jane Thomas; Helen Truby; Kevin Whelan Journal: Genes Nutr Date: 2013-07-17 Impact factor: 5.523
Authors: Tien M Truong; Jeffrey L Apfelbaum; Emily Schierer; Keith Danahey; Brittany A Borden; Theodore Karrison; Sajid Shahul; Magdalena Anitescu; Rebecca Gerlach; Randall W Knoebel; David O Meltzer; Mark J Ratain; Peter H O'Donnell Journal: Pharmacogenet Genomics Date: 2022-04-01 Impact factor: 2.089